$1.891.89 +0.010.01 |(+0.530.53 %)
52W H: 4.9452W L: 1.6Beta: 3.41
About Black Diamond Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.blackdiamondtherapeutics.com/
Frequently Asked Questions
What is the 52-week range for BDTX?
The 52-week high is $4.94 and the 52-week low is $1.6.
What is the P/E ratio for BDTX?
The P/E ratio data is currently unavailable.
What is the dividend yield for BDTX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -38.80%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.23.
Analyst Recommendation Trends
Wall Street analyst consensus for BDTX over the last few months:
2026-09-01
Buy: 7
S.Buy: 5
Hold: 2
Sell: 0
2026-08-01
Buy: 8
S.Buy: 5
Hold: 2
Sell: 0
2026-07-01
Buy: 8
S.Buy: 5
Hold: 2
Sell: 0
2026-06-01
Buy: 8
S.Buy: 5
Hold: 2
Sell: 0
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-18 | Raman Prakash | +6,801 | $1.93 | $13,126 |
| 2026-09-18 | Behbahani Ali | +7,707 | $1.93 | $14,875 |
| 2026-06-19 | Raman Prakash | +7,907 | $1.66 | $13,126 |
| 2026-06-19 | Behbahani Ali | +8,961 | $1.66 | $14,875 |
| 2026-03-20 | Raman Prakash | +6,105 | $2.15 | $13,126 |
| 2026-03-20 | Behbahani Ali | +6,919 | $2.15 | $14,876 |
| 2026-01-21 | Jones Erika | +200,000 | - | - |
| 2026-01-21 | Buck Elizabeth | +250,000 | - | - |
| 2026-01-21 | Velleca Mark A. | +600,000 | - | - |
| 2026-01-21 | Yurasov Sergey | +250,000 | - | - |
| 2026-01-21 | Hatzis-Schoch Brent | +250,000 | - | - |
| 2025-12-12 | Raman Prakash | +4,665 | $2.76 | $12,875 |
| 2025-12-12 | Behbahani Ali | +5,208 | $2.76 | $14,374 |